Thomas D. Nolin

7.4k total citations · 1 hit paper
135 papers, 4.3k citations indexed

About

Thomas D. Nolin is a scholar working on Pharmacology, Nephrology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Thomas D. Nolin has authored 135 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pharmacology, 33 papers in Nephrology and 30 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Thomas D. Nolin's work include Pharmacogenetics and Drug Metabolism (26 papers), Pharmacological Effects and Toxicity Studies (23 papers) and Drug Transport and Resistance Mechanisms (18 papers). Thomas D. Nolin is often cited by papers focused on Pharmacogenetics and Drug Metabolism (26 papers), Pharmacological Effects and Toxicity Studies (23 papers) and Drug Transport and Resistance Mechanisms (18 papers). Thomas D. Nolin collaborates with scholars based in United States, Canada and United Kingdom. Thomas D. Nolin's co-authors include Jonathan Himmelfarb, Marc Ghannoum, Maggie McMenamin, Robert S. Hoffman, Valéry Lavergne, Sophie Gosselin, Jason R. Stubbs, Robert C. Owens, E. J. C. Goldstein and Andrew J. Ocque and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Circulation.

In The Last Decade

Thomas D. Nolin

128 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden

2015 358 citations Jason R. Stubbs, Cassandra Johnson et al. Journal of the American Society of Nephrology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas D. Nolin United States	39	862	819	736	664	640	135	4.3k
Dario Cattaneo Italy	38	637 0.7×	747 0.9×	795 1.1×	230 0.3×	308 0.5×	233	5.8k
Vincent Pichette Canada	39	1.4k 1.6×	516 0.6×	976 1.3×	834 1.3×	392 0.6×	106	4.4k
Jérôme Biollaz Switzerland	41	333 0.4×	1.2k 1.5×	683 0.9×	432 0.7×	1.7k 2.7×	155	6.1k
Gary R. Matzke United States	34	673 0.8×	337 0.4×	634 0.9×	593 0.9×	268 0.4×	147	4.2k
Pierre Wallemacq Belgium	47	353 0.4×	789 1.0×	2.0k 2.7×	605 0.9×	443 0.7×	232	7.5k
Lynda Frassetto United States	37	1.8k 2.1×	849 1.0×	522 0.7×	374 0.6×	215 0.3×	108	4.8k
Marcus M. Reidenberg United States	41	285 0.3×	1.0k 1.3×	814 1.1×	710 1.1×	579 0.9×	140	4.9k
David W. Holt United Kingdom	48	325 0.4×	1.1k 1.4×	2.1k 2.9×	584 0.9×	1.5k 2.3×	237	8.9k
Gert A. Verpooten Belgium	34	895 1.0×	616 0.8×	506 0.7×	156 0.2×	168 0.3×	107	4.1k
Hillel Halkin Israel	39	301 0.3×	629 0.8×	352 0.5×	581 0.9×	1.4k 2.2×	128	5.4k

Countries citing papers authored by Thomas D. Nolin

Since Specialization

Citations

This map shows the geographic impact of Thomas D. Nolin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas D. Nolin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas D. Nolin more than expected).

Fields of papers citing papers by Thomas D. Nolin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas D. Nolin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas D. Nolin. The network helps show where Thomas D. Nolin may publish in the future.

Co-authorship network of co-authors of Thomas D. Nolin

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas D. Nolin. A scholar is included among the top collaborators of Thomas D. Nolin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas D. Nolin. Thomas D. Nolin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Flickinger, Katharyn L., Alexandra Weissman, Francis X. Guyette, et al.. (2025). Sustained metabolic reduction and hypothermia in humans. PLoS ONE. 20(4). e0321117–e0321117.

Nolin, Thomas D., et al.. (2025). Using Machine Learning to Predict Medication Therapy Problems among Patients with Chronic Kidney Disease. American Journal of Nephrology. 57(1). 120–130. 1 indexed citations

West, Raymond E., et al.. (2024). Simultaneous quantification of five antiretrovirals in human tissues using ultra-high performance liquid chromatography-tandem mass spectrometry methods for therapeutic drug monitoring at the sites of action. Journal of Chromatography B. 1241. 124164–124164.

Huang, David T., Sandra L. Kane‐Gill, Ryan Rivosecchi, et al.. (2024). Metformin for sepsis-associated AKI: a protocol for the Randomized Clinical Trial of the Safety and FeasibiLity of Metformin as a Treatment for sepsis-associated AKI (LiMiT AKI). BMJ Open. 14(4). e081120–e081120. 5 indexed citations

Peroumal, Doureradjou, Chetan V. Jawale, Wonseok Choi, et al.. (2024). The survival of B cells is compromised in kidney disease. Nature Communications. 15(1). 10842–10842. 3 indexed citations

Xue, Xiaonan, et al.. (2024). Impact of the 2021 CKD-EPI equation on anticancer pharmacotherapy in black and non-black cancer patients. Cancer Letters. 586. 216679–216679. 2 indexed citations

Rollman, Bruce L., et al.. (2024). Population Health Management and Guideline-Concordant Care in CKD. Journal of the American Society of Nephrology. 36(5). 869–881. 4 indexed citations

Luo, Zhangyi, Zhuoya Wan, Pengfei Ren, et al.. (2024). In Situ Formation of Fibronectin‐Enriched Protein Corona on Epigenetic Nanocarrier for Enhanced Synthetic Lethal Therapy. Advanced Science. 11(19). e2307940–e2307940. 11 indexed citations

Kimmel, Paul L., Thomas D. Nolin, Ivonne Hernandez Schulman, et al.. (2024). Opioid Prescriptions for US Patients Undergoing Long-Term Dialysis or with Kidney Transplant from 2011 to 2020. Journal of the American Society of Nephrology. 36(1). 108–121. 1 indexed citations

10.

Moore, Thomas J., et al.. (2023). Inclusion of Participants with CKD and Other Kidney-Related Considerations during Clinical Drug Development. Clinical Journal of the American Society of Nephrology. 18(4). 455–464. 7 indexed citations

11.

Jawale, Chetan V., Kritika Ramani, Dedong Li, et al.. (2020). Restoring glucose uptake rescues neutrophil dysfunction and protects against systemic fungal infection in mouse models of kidney disease. Science Translational Medicine. 12(548). 27 indexed citations

12.

Hudson, Joanna Q. & Thomas D. Nolin. (2018). Pragmatic Use of Kidney Function Estimates for Drug Dosing: The Tide Is Turning. Advances in Chronic Kidney Disease. 25(1). 14–20. 36 indexed citations

13.

Nolin, Thomas D. & Mark A. Perazella. (2018). Introduction to Nephropharmacology for the Clinician. Clinical Journal of the American Society of Nephrology. 13(7). 1083–1084. 1 indexed citations

14.

Johnson, Cassandra, et al.. (2018). Decreased Kidney Function Is Associated with Enhanced Hepatic Flavin Monooxygenase Activity and Increased Circulating Trimethylamine N-Oxide Concentrations in Mice. Drug Metabolism and Disposition. 46(9). 1304–1309. 24 indexed citations

15.

Nolin, Thomas D., et al.. (2016). Revisiting the Middle Molecule Hypothesis of Uremic Toxicity: A Systematic Review of Beta 2 Microglobulin Population Kinetics and Large Scale Modeling of Hemodialysis Trials In Silico. PLoS ONE. 11(4). e0153157–e0153157. 23 indexed citations

16.

Roberts, Darren M., Chris Yates, Bruno Mégarbane, et al.. (2014). Recommendations for the Role of Extracorporeal Treatments in the Management of Acute Methanol Poisoning. Critical Care Medicine. 43(2). 461–472. 106 indexed citations

17.

Naud, Judith, Thomas D. Nolin, Agnès Leblond, & Vincent Pichette. (2012). Current Understanding of Drug Disposition in Kidney Disease. The Journal of Clinical Pharmacology. 52(S1). 10S–22S. 60 indexed citations

18.

Nolin, Thomas D., Reginald F. Frye, Phuong Le, et al.. (2009). ESRD Impairs Nonrenal Clearance of Fexofenadine but not Midazolam. Journal of the American Society of Nephrology. 20(10). 2269–2276. 107 indexed citations

19.

Nolin, Thomas D.. (2008). Altered nonrenal drug clearance in ESRD. Current Opinion in Nephrology & Hypertension. 17(6). 555–559. 49 indexed citations

20.

Nolin, Thomas D., et al.. (2006). Hemodialysis Acutely Improves Hepatic CYP3A4 Metabolic Activity. Journal of the American Society of Nephrology. 17(9). 2363–2367. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact